We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

Over DrBond

Exclusive Knowledge and Networking App for Doctors.

DrBond is an exclusive app for doctors to stay in touch with the latest breaking news from healthcare, medicine & pharma. Stay connected with colleagues, pharma companies and start networking with key opinion leaders in the medical industry. The app also has a comprehensive and exclusive drug index for easy access to drug updates, drug information and dosage information. Read and share trending articles, medical news, and research papers on a daily basis. DrBond is the best knowledge-sharing and networking companion for every thinking doctor.

Key features:

1. Latest breaking news from healthcare, medicine & pharma

2. Best- in-class drug index

3. Easy access to curated articles from reputed medical journals

4. Easy peer-to-peer network and discussion forums

5. A platform to connect to Pharma companies of your interest

Coming soon:

We are constantly upgrading the app and you may see changes reflecting very soon to the user interface, but with the same great experience. Keep checking in daily.

Wat is er nieuw in de nieuwste versie 4.8

Last updated on Oct 2, 2016

Thanks for downloading

* You can now recommend brands of your choice and share your recommendations
* Bug fixes and ui enhancements

Vertaling Laden...

Aanvullende APP -informatie

Laatste Versie

Verzoek update van DrBond 4.8

Geüpload door

Ferdhian Bagazz

Android vereist

Android 4.1+

Meer Info

DrBond Screenshots

Talen
Abonneer u op APKPure
Wees de eerste die toegang krijgt tot de vroege release, nieuws en gidsen van de beste Android -games en apps.
Nee bedankt
Aanmelden
Succesvol ingeschreven!
Je bent nu geabonneerd op APKPure.
Abonneer u op APKPure
Wees de eerste die toegang krijgt tot de vroege release, nieuws en gidsen van de beste Android -games en apps.
Nee bedankt
Aanmelden
Succes!
Je bent nu geabonneerd op onze nieuwsbrief.